Introduction:
The global synthetic biology market is rapidly expanding, with a focus on engineering therapeutic cells and novel bio-production. According to recent studies, the market is expected to reach a value of $17.3 billion by 2026. This growth is driven by the increasing demand for personalized medicine and sustainable bio-based products.
Top 10 Global Synthetic Biology Platforms for Engineering Therapeutic Cells and Novel Bio-Production 2026:
1. Ginkgo Bioworks
Ginkgo Bioworks is a leading synthetic biology company with a production volume of over 100,000 liters per year. They specialize in engineering microbes for a variety of applications, including pharmaceuticals and agriculture.
2. Twist Bioscience
Twist Bioscience is known for its high-quality synthetic DNA products and has a market share of 15%. They provide custom gene synthesis services for research and industrial applications.
3. Zymergen
Zymergen focuses on bio-based materials and has an annual revenue of $300 million. Their platform combines machine learning with synthetic biology to design new materials with enhanced properties.
4. Synthace
Synthace offers software solutions for designing and optimizing biological experiments. They have a user base of over 15,000 researchers worldwide and are a key player in the synthetic biology software market.
5. Intrexon
Intrexon is a biotechnology company known for its work in gene editing and cell engineering. They have a trade value of $500 million and are expanding their presence in the pharmaceutical industry.
6. Codexis
Codexis specializes in enzyme engineering for the production of bio-based chemicals and pharmaceuticals. They have a production volume of 50,000 tons per year and are a key player in the industrial biotechnology market.
7. Amyris
Amyris is a renewable products company with a focus on sustainable ingredients for the beauty and health industries. They have an annual revenue of $150 million and are expanding into the nutraceutical market.
8. Genomatica
Genomatica is a leader in bio-based chemicals, with a market share of 10%. They have commercialized several sustainable products, including bio-based nylon and butylene glycol.
9. Evonetix
Evonetix is a startup company developing a novel gene synthesis platform based on semiconductor technology. They have received $30 million in funding and are expected to disrupt the gene synthesis market.
10. Inscripta
Inscripta provides gene editing tools for research and industrial applications. They have a user base of over 1,000 labs worldwide and are expanding their product offerings in the CRISPR market.
Insights:
Overall, the global synthetic biology market is poised for significant growth in the coming years, driven by advancements in gene editing, automation, and bioinformatics. The increasing demand for sustainable products and personalized medicine is also fueling innovation in therapeutic cell engineering and bio-production. By leveraging the top synthetic biology platforms mentioned above, companies can stay competitive in this rapidly evolving market. As the industry continues to mature, we can expect to see more collaborations between companies and academic institutions, leading to breakthrough discoveries and new applications for synthetic biology.
Related Analysis: View Previous Industry Report
